NASDAQ · Biotechnology

ELVN (ELVN) Stock

$60.46 +0.32% NASDAQ: ELVN Healthcare

Valuation

MetricValue
Price$60.46
Market Cap$4.32B
P/E Ratio-19.91
P/B Ratio5.68
P/S Ratio0.00
EPS (TTM)$-1.64
52-Week High$60.46
52-Week Low$14.79
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-26.64%
ROA-18.86%
ROCE-26.14%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio40.32

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-25.0M$-39.0M$-84.0M$-105.0M$-120.0M
Net Profit$-25.0M$-38.0M$-72.0M$-89.0M$-104.0M
EPS$-3.17$-6.03$-2.01$-1.89$-1.83
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$113.0M$83.0M$272.0M$326.0M$476.0M
Total Liabilities$6.0M$160.0M$26.0M$16.0M$17.0M
Cash$110.0M$76.0M$100.0M$124.0M$99.0M
Borrowings$0$0$0$0$0

Latest News

HMI Capital Pares Its Stake in AI Company nCino Barrons.com · Jul 10, 2026 Enliven Therapeutics Insider Sold Shares Worth $504,903, According to a Recent SEC Filing MT Newswires · Jul 8, 2026 Stocks To Watch: 14 Names Test And Tease New Buy Zones Investor's Business Daily · Jul 8, 2026 Enliven Therapeutics (ELVN) Stock Looks Overvalued As Returns Surge But Book Value Lags Simply Wall St. · Jul 4, 2026 What to Know About This $345,000 Enliven Insider Sale as the Stock Soars 130% Motley Fool · Jun 27, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-19.0M$-32.0M$-61.0M$-73.0M$-70.0M
Investing Cash Flow$0$-1.0M$-149.0M$-36.0M$-174.0M
Financing Cash Flow$0$-1.0M$73.0M$94.0M$0
Net Cash Flow$-20.0M$-34.0M$25.0M$24.0M$-25.0M
Free Cash Flow$-19.0M$-33.0M$-61.0M$-73.0M$-70.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-18.38
FCF Yield-2.55%
Quick Ratio40.32
Interest Coverage—
Return 1Y148.65%
Return 3Y178.78%
Return 5Y149.12%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About ELVN

ELVN stock trades at $60.46 with a market capitalization of $4.32B. The stock is valued at a price-to-earnings (P/E) ratio of -19.91, price-to-book of 5.68, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $14.79 and $60.46, and currently trades at its 52-week high.

On profitability, ELVN generates a return on equity (ROE) of -26.64%, return on capital employed of -26.14%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides